Nj State Employees Deferred Compensation Plan Tg Therapeutics, Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $761 Million
- Q1 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 91,600 shares of TGTX stock, worth $3.26 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
91,600
Previous 91,600
-0.0%
Holding current value
$3.26 Million
Previous $2.76 Million
30.98%
% of portfolio
0.47%
Previous 0.34%
Shares
3 transactions
Others Institutions Holding TGTX
# of Institutions
416Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$556 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$406 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$265 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$117 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$101 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.18B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...